Teladoc Health (TDOC) Launches New AI Tools, Is It Still 63% Below Fair Value?

Teladoc Health (TDOC) has just rolled out two AI tools inside its Solo platform, SoloVitals and SoloScribe, giving hospitals new ways to collect remote vital signs and automate documentation across virtual visits.

Recent news flow at Teladoc Health has been active, with the SoloVitals and SoloScribe launch following a leadership change in the legal team in late September. Yet the share price has fallen 40.3% over the past 90 days and the 1-year total shareholder return is down 37.4%, pointing to fading momentum over both shorter and longer periods.

Capitalize on Teladoc Health's AI push by exploring a curated set of other healthcare AI plays in our 32 healthcare AI stocks that may be positioned for the next move.

Teladoc Health is rolling out fresh AI tools while the share price has been sliding hard. Is this drop really about the business, or has sentiment simply moved on faster than the fundamentals?

Most Popular Narrative: 63% Undervalued

Teladoc Health last closed at $5.54, while the most followed narrative on the stock, according to AnimalDoctorKwon, pegs fair value at $15. That is a wide gap, and it rests on a view that the current price does not reflect the cash generation and balance sheet described in the thesis.

Despite the market narrative of a failing pandemic stock, Teladoc’s underlying financial engine tells a radically different story.

In reality, Teladoc is a cash-generative healthcare utility with: 1. $750M+ in hard cash protecting the downside. 2. $130M to $170M in annual free cash flow. 3. An expanding insurance-reimbursed mental health model.

See why 3 investors see Teladoc Health as 63% undervalued.

Result: Fair Value of $15 (UNDERVALUED)

Still, Teladoc Health’s story can break if BetterHelp’s insurance shift squeezes margins, or if rising telehealth competition keeps pressuring pricing and member growth.

Find out about the key risks to this Teladoc Health narrative.

Next Steps

The debate around Teladoc Health is clearly split, with risks on one side and clear potential on the other. Move quickly, weigh the hard numbers yourself, then drill into the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Teladoc Health?

If Teladoc Health has your attention, do not stop there. Broaden your watchlist and give yourself more ways to potentially benefit from future market shifts.

• Target stability first and let volatility take a back seat by scanning 31 resilient stocks with low risk scores, which keep risk scores tight while still offering meaningful exposure.
• Hunt for value where quality and pricing line up by reviewing the 27 high quality undervalued stocks, which pair solid fundamentals with prices that may not fully reflect them.
• Spot fresh ideas before the crowd arrives by working through the 20 high quality undiscovered gems, which combine strong financial profiles with relatively low attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com